These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Overview and recent advances in the targeting of medulloblastoma cancer stem cells. Paul MR; Zage PE Expert Rev Anticancer Ther; 2021 Sep; 21(9):957-974. PubMed ID: 34047251 [No Abstract] [Full Text] [Related]
5. Clinicopathological features of medulloblastoma: an overview with an emphasis on molecular biology. de Haas TG; Kool M Clin Neuropathol; 2007; 26(3):93-110. PubMed ID: 19157001 [TBL] [Abstract][Full Text] [Related]
6. New Approaches in Targeted Therapy for Medulloblastoma in Children. Maier H; Dalianis T; Kostopoulou ON Anticancer Res; 2021 Apr; 41(4):1715-1726. PubMed ID: 33813375 [TBL] [Abstract][Full Text] [Related]
7. Anaplasia and grading in medulloblastomas. Eberhart CG; Burger PC Brain Pathol; 2003 Jul; 13(3):376-85. PubMed ID: 12946027 [TBL] [Abstract][Full Text] [Related]
19. Tailoring Medulloblastoma Treatment Through Genomics: Making a Change, One Subgroup at a Time. Holgado BL; Guerreiro Stucklin A; Garzia L; Daniels C; Taylor MD Annu Rev Genomics Hum Genet; 2017 Aug; 18():143-166. PubMed ID: 28475368 [TBL] [Abstract][Full Text] [Related]
20. Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables. Ellison DW; Kocak M; Dalton J; Megahed H; Lusher ME; Ryan SL; Zhao W; Nicholson SL; Taylor RE; Bailey S; Clifford SC J Clin Oncol; 2011 Apr; 29(11):1400-7. PubMed ID: 20921458 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]